{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-092268","form_type":"8-K","ticker":"STOK","cik":"0001623526","company_name":"Stoke Therapeutics, Inc.","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.845093+00:00","generated_at":"2026-05-31T11:47:16.369485+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Stoke Therapeutics Q2 net loss $25.7M; FDA lifts partial clinical hold on zorevunersen","bullets":["FDA removed Partial Clinical Hold on zorevunersen for Dravet syndrome; planning Phase 3 registrational study.","Q2 revenue $4.8M (vs. -$2.5M prior year); net loss $25.7M ($0.46/shr) vs. $30.7M ($0.69/shr) prior year.","Cash, cash equivalents, and marketable securities totaled $282M as of June 30, 2024.","On track to initiate Phase 1 OSPREY study of STK-002 for Autosomal Dominant Optic Atrophy in 2024.","Regulatory discussions ongoing; update on Phase 3 registrational plans for zorevunersen expected H2 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-092268","json":"https://secwatch.observer/filing/0000950170-24-092268.json","markdown":"https://secwatch.observer/filing/0000950170-24-092268.md","text":"https://secwatch.observer/filing/0000950170-24-092268.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1623526/000095017024092268/0000950170-24-092268-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1623526/000095017024092268/stok-20240807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:47:16.369485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}